| 000 | 01822 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514050959.0 | ||
| 264 | 0 | _c20030321 | |
| 008 | 200303s 0 0 eng d | ||
| 022 | _a1590-8658 | ||
| 024 | 7 |
_a10.1016/s1590-8658(02)80204-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKohn, A | |
| 245 | 0 | 0 |
_aAnti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients. _h[electronic resource] |
| 260 |
_bDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver _cSep 2002 |
||
| 300 |
_a626-30 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Antineutrophil Cytoplasmic _xblood |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylprednisolone _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aPrantera, C | |
| 700 | 1 | _aPera, A | |
| 700 | 1 | _aCosintino, R | |
| 700 | 1 | _aSostegni, R | |
| 700 | 1 | _aDaperno, M | |
| 773 | 0 |
_tDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver _gvol. 34 _gno. 9 _gp. 626-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1590-8658(02)80204-3 _zAvailable from publisher's website |
| 999 |
_c12213603 _d12213603 |
||